PURPOSE We wanted to evaluate the predictive value of percentage change in antenatal maternal body mass index (BMI) as it relates to macrosomia, as well as to compare change in pregnancy BMI with existing weight gain guidelines.
INTRODUCTION
N eonatal macrosomia affects between 3% and 15% of all pregnancies and is associated with shoulder dystocia, brachial plexus injury, skeletal injuries, meconium aspiration, perinatal asphyxia, hypoglycemia, and fetal death. 1, 2 Maternal complications of macrosomia include prolonged labor, labor augmentation with oxytocin, cesarean delivery, postpartum hemorrhage, infection, 3rd-and 4th-degree lacerations, thromboembolic events, and anesthetic accidents. 2 Maternal obesity, multiparity, previous macrosomic infant, male fetus, maternal birth weight, maternal diabetes, prepregnancy body mass index (BMI), and excessive maternal weight gain are all risk factors for fetal macrosomia. 1, 3 Although maternal weight gain is frequently cited as a risk factor for macrosomia, 3 current weight gain recommendations 4 and consensus guidelines and are not evidence based. Additionally, there exist substantial variation in the literature and limited evidence supporting the strength of association between these risk factors and macrosomia. 5 Chad A. Asplund, MD 1 Dean A. Seehusen, MD, MPH
The purpose of this study was to evaluate the predictive value of percentage change in antepartum maternal BMI in predicting neonatal macrosomia, as well as to compare change in antepartum maternal BMI with existing weight gain guidelines.
METHODS
Based on personal experience and a small pilot study, we hypothesized that an increase in antenatal BMI by greater than 25% may be a predictor of macrosomia. The protocol was approved by the Eisenhower Army Medical Center (EAMC) institutional review board. We studied military benefi ciaries whose babies were delivered by EAMC physicians from June 2006 to December 2006. The main eligibility criterion was the delivery of a live-born fetus at 37 to 42 weeks' gestation. Exclusion criteria included gestational diabetes, multiple gestation, entry to care after the fi rst trimester, delivery before 37 weeks, or charts missing any of the data points.
Sample size for a power of 0.80 and an α of .05 was determined by using the lower end of the American College of Obstetrics and Gynecology (ACOG)-supported prevalence of fetal macrosomia of 10% plus a conservative value of relative risk supported in the literature of 2.5 (range, 2.0-5.0), 1 We used logistic regression analysis to compute the association between percentage change in BMI and fetal weight and compared percentage change in BMI with current weight gain guidelines. We used receiver operator character (ROC) curve analysis to assess the accuracy of this technique for predicting a fetal of weight greater than 4,000 g. SPSS 12.0 (SPSS Inc, Chicago, Illinois) was used for all data analyses.
RESULTS
A total of 238 EAMC deliveries occurred from June 2006 to December 2006. Fifty-two were excluded (30 were late entries to care, 13 mothers had gestational diabetes, 6 fi les had missing data, and 3 were multiple gestations). Among the 186 included in the fi nal analysis, 56.5% of mothers were white and 25.8% were black. Average maternal age was 26.5 years; 32.8% were primigravidas. (Table 1) Of the 186 infants, 15.6% were macrosomic (n = 29). Of those macrosomic infants, 86.2% (25/29) of their mothers had a percentage change in antenatal BMI of 25% or greater compared with 6.6% (10/157) of the mothers of normal-weight infants (P <.001), which yielded a relative risk 13.5 (95% confi dence interval [CI], 7.3%-25.1%). Percentage change in antenatal maternal BMI of 25% or greater had a sensitivity of 86.2% (95% CI, 68.3%-96.1%), specifi city of 93.6% (95% CI, 88.6%-96.9%), a positive predictive value of 71.4% (95% CI, 53.7%-85.4%), and a negative predic- The data were further stratifi ed by entry BMI and evaluated against the existing Institute of Medicine (IOM) weight gain guidelines. 4 (Table 2) Gaining weight in excess of the IOM recommendations was a weaker predictor of macrosomia than percentage change in maternal BMI of 25% or greater. Furthermore, 11% of women whose weight gain was within or below the IOM guidelines also gave birth to macrosomic infants. Of these, 71% would have been predicted by a 25% or greater antenatal increase in BMI.
DISCUSSION
Although there is considerable variation in the defi nition of macrosomia in the literature, 6 4,000 g is the most widely used value and is the value at which maternal and neonatal complications increase. 7 It is also the most common weight used when evaluating the predictive value of various methods to determine macrosomia antenatally. 7 Because one goal was to compare our method with those already published, we also chose 4,000 g as our defi nition of macrosomia.
Several studies have found maternal estimate of birth weight offers a sensitivity of approximately a Sensitivity = 75%, specifi city = 100%, positive predictive value = 100%, negative predictive value = 98%.
b Sensitivity = 70%, specifi city = 97%, positive predictive value = 78%, negative predictive value = 96%.
c Sensitivity = 100%, specifi city = 84%, positive predictive value = 68%, negative predictive value = 100%. 
56%
. 8, 9 Clinical palpation is the traditional method used, but this method has a sensitivity similar to that of maternal estimate and is known to have a large predictive error, especially with large infants. 10 Risk factor assessment has also been studied, but it has poor sensitivity and specifi city. 1 There have also been many studies of the use of sonography, with many different fetal measurement algorithms used, 4 of which specifically looked at prediction of neonatal macrosomia. [11] [12] [13] [14] [15] These studies showed a sensitivity of 59%, with area under the ROC curves from 0.75-0.85. Finally, several birthweight prediction algorithms have been used, with a sensitivity of 54% to 58% and a specifi city of 84% to 92%. 11, 16 Previous studies have suggested that obesity before pregnancy contributes to macrosomia, and when prepregnancy BMI increases, there is an increase in neonatal macrosomia and poor delivery outcomes. [17] [18] [19] Although prepregnancy BMI and maternal weight gain correlate with fetal birth weight, our fi ndings suggest that percentage change in maternal BMI may offer a better estimation of overall change in maternal body composition and fetal weight. Our report appears to be the fi rst published study showing that antenatal increase in BMI of 25% or greater is a sensitive predictor of fetal macrosomia, regardless of initial BMI. Also, BMI is calculated by most electronic medical charting systems and is readily available to clinicians at point of care. Although the previous methods are accurate and have clinical utility, many of them require special equipment or formulas, and none is singularly predictive. Our lowtech method may be used as a sole predictor of neonatal macrosomia or to augment other methods, such as palpation, sonography, or prediction equations.
Guidelines for maternal weight gain have existed since the 1990 IOM report recommending weight gain for a specifi c prepregnancy BMI category (Table  3) , which the ACOG adopted in 1993. 4, 20 Maternal weight gain recommendations, however, were based on observational studies in an attempt to balance the benefi ts of increased fetal growth with the risks of complicated labor and delivery, and the recommendations were not evidence-based. 4 Using our method, the upper limit of weight gain may be individualized for obstetric patients. For example, for a 5 foot 1 inch tall woman who started pregnancy at a weight of 110 pounds (BMI = 20.8), an increase in BMI of 25% (BMI = 26.0) would be caused by a weight gain of 27 pounds; therefore, 27 pounds could be used as the upper limit of weight gain, compared with the 35 to 40 pounds recommended by the IOM guidelines.
The limitations of our study include our unique patient population and their access to medical care. Our military population has good access to care at no cost, may be more physically fi t than the civilian sector, and may possess lower prepregnancy weight and weight gain during pregnancy. Also, in an effort to minimize confounders, we excluded women with gestational diabetes. This exclusion may be viewed as a limitation, because detecting macrosomia in diabetic patients may actually help to direct management decisions.
In conclusion, fetal macrosomia has been consistently associated with neonatal and maternal complications. Any indicator that helps diagnose macrosomia may allow clinicians to make better choices regarding timing and mode of delivery, as well as prepare for emergencies. Our fi ndings support that regardless of initial pregnancy BMI or total amount of maternal weight gain, an antepartum maternal BMI increase of 25% or greater is predictive of neonatal weight greater than 4,000 g. This method is easy to use without any special equipment or expert clinical skills, and it has shown a better sensitivity and specifi city than previously described methods. Finally, our method may allow clinicians to individualize maternal weight gain recommendations, replacing previous IOM guidelines.
Antenatal percentage change in BMI was highly predictive of macrosomia in our unique patient population. Future studies in a larger, more heterogeneous population are needed. Prospective studies will be desirable to test antenatal change in BMI as a means for infl uencing maternal weight gain and detecting and managing delivery of macrosomic fetuses. From the Institute of Medicine. 4 
